methamphetamine prescription
Selected indexed studies
- Prescription of Controlled Substances: Benefits and Risks. (, 2026) [PMID:30726003]
- Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature. (Int J Ment Health Nurs, 2023) [PMID:36978242]
- Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. (Psychopharmacology (Berl), 2020) [PMID:32601988]
_Worker-drafted node — pending editorial review._
Connections
methamphetamine prescription is a side effect of
Sources
- Melatonin as an antioxidant: under promises but over delivers. (2016) pubmed
- Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. (2020) pubmed
- Prescription of Controlled Substances: Benefits and Risks. (2026) pubmed
- Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature. (2023) pubmed
- Commonly prescribed medications and potential false-positive urine drug screens. (2010) pubmed
- Regional Disparities in Prescription Methamphetamine and Amphetamine Distribution Across the United States. (2023) pubmed
- Neonatal abstinence syndrome. (2014) pubmed
- An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations. (2020) pubmed
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada. (2024) pubmed
- Associations of prescription stimulant misuse with subsequent methamphetamine use among a U.S. cohort of HIV-vulnerable sexual and gender minorities who have sex with men. (2021) pubmed